- Tools for Investors
- Stock News
- Investing Ideas
- Econ & Policy
- Personal Finance
S&P 500 (NYSE:SPY) component Mylan (NASDAQ:MYL) will unveil its latest earnings on Thursday, July 26, 2012. Mylan is a global pharmaceutical company that develops, licenses, manufactures, markets, and distributes pharmaceuticals and active pharmaceutical ingredients.
Mylan Earnings Preview Cheat Sheet
Wall St. Earnings Expectations: The average estimate of analysts is for net income of 55 cents per share, a rise of 5.8% from the company’s actual earnings for the same quarter a year ago. During the past three months, the average estimate has moved down from 57 cents. Between one and three months ago, the average estimate moved down. It has been unchanged at 55 cents during the last month. Analysts are projecting profit to rise by 26.5% versus last year to $2.48.
Past Earnings Performance: The company has beaten estimates the last four quarters and is coming off a quarter where it topped forecasts by one cent, reporting profit of 52 cents per share against a mean estimate of net income of 51 cents per share.
Investing Insights: Is TV the Next Bullish Catalyst for Apple’s Stock?
A Look Back: In the first quarter, profit rose 23.9% to $129.1 million (30 cents a share) from $104.2 million (23 cents a share) the year earlier, exceeding analyst expectations. Revenue rose 9.9% to $1.59 billion from $1.45 billion.
Stock Price Performance: Between May 23, 2012 and July 20, 2012, the stock price had risen $1.41 (6.7%), from $20.89 to $22.30. The stock price saw one of its best stretches over the last year between July 12, 2012 and July 19, 2012, when shares rose for six straight days, increasing 4.8% (+$1.03) over that span. It saw one of its worst periods between September 27, 2011 and October 4, 2011 when shares fell for six straight days, dropping 12.7% (-$2.35) over that span.
Wall St. Revenue Expectations: On average, analysts predict $1.66 billion in revenue this quarter, a rise of 5.7% from the year-ago quarter. Analysts are forecasting total revenue of $6.88 billion for the year, a rise of 12.2% from last year’s revenue of $6.13 billion.
This upcoming earnings announcement will be a chance to build on positive earnings momentum over the last three quarters. Net income rose 9.4% in the third quarter of the last fiscal year and more than sixfold in the fourth quarter of the last fiscal year before increasing again in the first quarter.
On the top line, the company is looking to build on four-straight revenue increases heading into this earnings announcement. Revenue rose 15% in the second quarter of the last fiscal year, 16.3% in the third quarter of the last fiscal year and 6.7% in the fourth quarter of the last fiscal year before increasing again in the first quarter.
Balance Sheet Analysis: The company’s current ratio of assets to liabilities came in at 1.77 last quarter. The current ratio is an indication of a firm’s liquidity and ability to meet creditor demands and generally, for every dollar the company owes in the short term, it has that figure available in assets that can be converted to cash in the short term.
Analyst Ratings: With 11 analysts rating the stock a buy, one rating it a sell and five rating the stock a hold, there are indications of a bullish stance by analysts.
Stocks with improving earnings metrics are worthy of your extra attention. In fact, “E = Earnings Are Increasing Quarter-Over-Quarter” is a core component of our CHEAT SHEET investing framework for this very reason. Don’t waste another minute — click here and get our CHEAT SHEET stock picks now.
(Company fundamentals by Xignite Financials. Earnings estimates provided by Zacks)
Don’t Miss These Hot Additional Stories:
Don't miss one of the biggest bull markets in history! Covers Gold, Silver, Gold & Silver stocks, and miners.
There's always a bull market in some sector! Find the best opportunities in commodities.